Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
By Unknown
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Podcast Description
Listen to a Pharma Show podcast, which focuses on providing professionals in the pharmaceutical industry with up-to-the-minute information and insights from the experts.
| Name | Description | Released | Price | ||
|---|---|---|---|---|---|
|
1 |
Lundbeck: Be Audit & Inspection Ready | The primary focus of Pharmacovigilance is patient safety. Raghavendra Pai, regional Pharmacovigilance Manager, Lundbeck Asia Pacific, explains the practial steps to train local pharmacovigilance staff to meet country-specific inspection and aud | 5/30/12 | Free | View In iTunes |
|
2 |
Implementing an Effective Pharamcovigilance Programme in India | With a population of 1.9 billion and a multi-medicine model, the reporting of adverse reactions in medicine in India is crucial. The pharmacovigilance programme was launched in India in 2010 to provide education about drug safety. Dr. Y.K Gupta, Co-o | 5/29/12 | Free | View In iTunes |
|
3 |
Top Tips For Preparing and Running Effective Webinars in Pharma | Do you want to improve engagement levels during and after your webinar? In this interview Ken Molay, President of Webinar Success and prolific blogger on the subject of Web conferencing and its applications, speaks to Andrea Charles from Pharma IQ,&n | 5/24/12 | Free | View In iTunes |
|
4 |
Joanne Chio on Innovation in Early Phase Trials | Joanne Chio, Head of Clinical Trials at the Haematology- Oncology Research Group ( HORG), National University Cancer Institute, Singapore (NCIS), speaks to Andrea Charles from Pharma IQ about innovation in early phase trials. Chio also shares he | 5/23/12 | Free | View In iTunes |
|
5 |
Pfizer's Head of Clinical Innovation on the Future of Clinical Trials | There are mounting challenges around the sustainability of clinical trials as the pharmaceutical industry is faced with increasingly complex and expensive trials. But new models and collaberations are emerging, creating new opportunity around w | 5/20/12 | Free | View In iTunes |
|
6 |
Celebrating International Clinical Trials Day: Starting with the Supply Chain | International Clinical Trials' Day will be celebrated on the 20th of May in order to celebrate the day that James Lind started his famous trial on the 20th of May 1747. In a series of interviews to celebrate this date, Pharma IQ | 5/16/12 | Free | View In iTunes |
|
7 |
Dr. Akhilesh Sharma, Senior VP, Dr. Reddy's Laboratories on Target Engagement, Translational Strategies and Timelines in Early | Dr. Akhilesh Sharma, Senior Vice President and Global Head of Global Medical Affairs at Dr. Reddy's Laboratories, joins Andrea Charles from Pharma IQ, to discuss emerging trends in early phase clinical studies and the latest strate | 5/13/12 | Free | View In iTunes |
|
8 |
Discover how to take Time and Cost out of Clinical Trials in 11 minutes | The proportion of clinical trials in Phase I has increased significantly in the last number of years. This coupled with a number of Phase III failures has put increased emphasis on making the right decision as early as possible. Nancy Widener, Executive D | 5/10/12 | Free | View In iTunes |
|
9 |
How to Deliver Cost Effective Pharmaceutical Global Artwork | Labelling and Artwork are still the highest causes of the recall of pharmaceutical products. Andrew Love, Vice President at Pharmaceutical Advisory Services, Be4ward Ltd, and former Director of Global Pack Management from GlaxoSmithKline,& | 4/30/12 | Free | View In iTunes |
|
10 |
Insights into Discovery of Structured Data | On behalf of Legal IQ, Jim Vint, Managing Director at Navigant, interviews Patrick Oot, Co-Founder and GC, Electronic Discovery Institute, Special Counsel, Electronic Discovery at US Securities and Exchange Commission about the latest developments in Info | 4/24/12 | Free | View In iTunes |
|
11 |
How to Dodge Common Pitfalls Leading to Prosecution in the Pharma Industry | Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company p | 4/17/12 | Free | View In iTunes |
|
12 |
The Pharma Supply Chain: Developing and Implementing Strategies for Aviation Security | The distribution of clinical supplies can be a challenge for any trial. Paul Wiberg-Jørgensen, Vice President, Logistics, Statens Serum Institute, joins Andrea Charles from Pharma IQ, to discuss w hat steps the SSI is taking to overcome the ch | 4/3/12 | Free | View In iTunes |
|
13 |
Eli Lilly Face Challenges involved in Complying to Serialisation Requirements with Success | Eli Lilly's experience of complying with strict Turkish serialisation requirements has taught them how to handle future implementation of serialisation globally in a more effective manner, explains Hicham Safine, Europe/AMEA/CIS Quality Consultant at | 3/19/12 | Free | View In iTunes |
|
14 |
Identifying Formulations to Progress Compounds Solubility | Solving solubility problems is one of the leading challenges in drug development, as poorly soluble compounds are estimated to account for 60% of compounds. Preclinical development encompasses the activities that link the drug discovery process in the lab | 3/19/12 | Free | View In iTunes |
|
15 |
Lessons Learnt: A Multi-Partner Approach to Clinical Trials | With several thousand clinical trials currently running in Scandinavia, Nordic biotech and pharma companies, CROs and research institutions are increasingly extending their reach into other geographic regions. In this candid interview, Maria Ohl | 3/14/12 | Free | View In iTunes |
|
16 |
Steps to Expediting Time-to-Market for Insoluble Drug Candidates | Improving the solubility of new chemical entities has proven to be one of the biggest hurdles to overcome in pharmaceutical drug development, and companies are always looking for new strategies for increasing bioavailability of new drugs. Many companies a | 3/14/12 | Free | View In iTunes |
|
17 |
Eight Minutes to Best Practice on Effective Implementation & Integration of Disposables (Single-Use) Systems | Disposables (Single-Use) systems have been widely established in pharmaceutical and biotechnology companies’ biomanufacturing processes across Europe and the US with proven economic and fast product changeover benefits. Rece | 3/6/12 | Free | View In iTunes |
|
18 |
Maximising Packaging and Labelling to ensure Patient Compliance | Up to 50% of patients may not be taking their medication as prescribed. Tassilo Korab, Executive Director for the European Healthcare Packaging Compliance Council explains how the Pharmaceutical Industry can optimise packaging and labelling to i | 2/28/12 | Free | View In iTunes |
|
19 |
Effective Implementations of New CDS Software in FDA Regulated Industries | Purchasing new software is a significant commercial and resource investment for any level of the pharmaceutical industry. Smooth implementation is essential to minimizing the impact it will have on the organization and internal processes. In this podcast, | 2/15/12 | Free | View In iTunes |
|
20 |
The Impact of Globalisation on Ensuring Data Quality and Usability in Laboratory Informatics | Informatics has been an important catalyst for globalisation, but how is globalisation impacting laboratory informatics? In this interview Eduard de Vries, Senior Manager IT Reference Laboratories & Asia-Pacific from IDEXX Laboratories and | 2/2/12 | Free | View In iTunes |
|
21 |
Managing Clinical Trials and Drug Approvals in China | China is now the world’s third-largest pharmaceutical market. In this interview Stefano Accorsi, Director, International Regulatory Affairs, International Comercial Operations, Chiesi Farmaceutici S.p.A, speaks to Andrea Charles from Pharma IQ,  | 12/21/11 | Free | View In iTunes |
|
22 |
Preventing Type 2 Diabetes in the MENA Region | Diabetes is a global threat. Researchers estimate that 26.6 million people in the Middle East and North Africa currently have diabetes. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. In this interview Pr | 12/19/11 | Free | View In iTunes |
|
23 |
Understanding of Genomic Structural Variations in Cancer | In a session that will be discussed at the Next Generation Sequencing Asia Conference. Dr. Axel Hillmer, Senior Research Scientist, for the Genome Institute of Singapore, outlines some of the challenges to understand the genomic structural variations in c | 12/18/11 | Free | View In iTunes |
|
24 |
Understanding Human Brain Evolution Through Transcriptome Sequencing | Philipp Khaitovich, Group Leader Comparative Biology Group, PICB Shanghai - Chinese Academy of Sciences and German Max Plank Society spoke to Bryan Camoens and explains to us how he uses transcriptome sequencing to understand the human brain. Have Your Sa | 12/18/11 | Free | View In iTunes |
|
25 |
Clinically Relevant Drug Transporters: Understanding DDI with a View to Better Prediction and Control | How is the industry seeking to understanding DDI with a view to better prediction and control? How has the current technology landscape changed following the publication of the ITC white paper? What progress do you expect we will see in clinical | 12/14/11 | Free | View In iTunes |
|
26 |
Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions | In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas fo | 12/12/11 | Free | View In iTunes |
|
27 |
Predictions for Targeted Drug Delivery with David Elder and Brendan Griffin | In this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how they are tackling major challenges in drug developme | 12/4/11 | Free | View In iTunes |
|
28 |
Meeting Regulatory Approval and Improving Distribution Operations across the Middle East | In this interview Hassan Bibi, Regional Regulatory Affairs Director NEWAAT - Janssen Pharmaceutical companies of Johnson and Johnson, speaks to Andrea Charles from Pharma IQ, about overcoming the 3 main challenges with regards to meeting regulatory approv | 11/20/11 | Free | View In iTunes |
|
29 |
Making a Business Case for PAT and QbD Implementation | What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! In this presentation Brett Cooper Research Fellow, MSD Development Laboratories, speaks to Andrea Charles from Pharma IQ, about the | 10/30/11 | Free | View In iTunes |
|
30 |
Overcoming Challenges in NMR Processing and Analysis | Dr. Till Kühn, Product Manager at Bruker Biospin, speaks to Andrea Charles from Pharma IQ, about recent NMR spectroscopy trends such as higher sensitivity , smaller sample sizes and automation and the challenges routine NMR users | 10/26/11 | Free | View In iTunes |
|
31 |
Scale-Up and Manufacturing of Regenerative Medicine | When introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patient use. In this podcast, William Fodor, Director of Tran | 9/28/11 | Free | View In iTunes |
|
32 |
Hospital-Based Cancer Registries Have a Pivotal Role to Play in Cancer Control | In this podcast Amid Abu Hmaidan, Director of the Hospital Cancer Registry at King Hussein Cancer Center, the only cancer center in Jordan, joins Pharma IQ to discuss the benefits of using hopsital-based cancer registries to support clinical trials a | 9/28/11 | Free | View In iTunes |
|
33 |
Why Not Sequence the Whole Genome? | Professor René Bernards , Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-generation DNA sequencing in oncology research, | 9/13/11 | Free | View In iTunes |
|
34 |
Top Tips for Re-designing Downstream Processes | In this podcast Sudip Kumar Majumder, Principal Scientist at Intas Biopharmaceuticals India, speaks to Andrea Charles from Pharma IQ about streamlining and redesigning the downstream process and innovations on the horizon that will change the cu | 9/12/11 | Free | View In iTunes |
|
35 |
E-Discovery Technology: Beware of Vapourware! | HB Gordon, eDiscovery Analyst, Legal Affairs, Teva Pharmaceuticals USA, joins Andrea Charles from Pharma IQ, to discuss the current challenges associated with e-discovery in pharma and biotech, approaching cross-border privacy and data prot | 9/12/11 | Free | View In iTunes |
|
36 |
Increasing Efficiency in Drug Discovery & Development with Aptuit Medicines Research Centre | In this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profiling Preclinical Technologies, Sergio Raimondo, Head of Sc | 9/7/11 | Free | View In iTunes |
|
37 |
Alzheimer's Disease Drug Discovery and the Aging Brain | Ottavio Arancio, Professor, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University, speaks to Andrea Charles from Pharma IQ, about the goals of his current research, how the landscape for Alzheimer&# | 8/17/11 | Free | View In iTunes |
|
38 |
The Biggest Threats to the Safety of Biologics | Dr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants present the most problems. Potts also shares her insights | 8/17/11 | Free | View In iTunes |
|
39 |
Addressing the Commercial Importance of Supplementary Protection Certificates | As major patents on blockbuster drugs continue to expire, Chris Hayes, Senior Advisor, Intellectual Property Rights - Launched Products, Lundbeck, and Andrea Charles from Pharma IQ discuss how return-on-investment can be maximised and the key drivers for | 8/15/11 | Free | View In iTunes |
|
40 |
Biorepositories and Biospecimen Research - Science and Standards | Kimberly Myers, Office of Biorepositories and Biospecimen Research, National Cancer Institute, NIH, DHHS, joins Andrea Charles from Pharma IQ, for an update on the progess of the NCI's Centre for Biospecimen Science and Standards, and how i | 8/7/11 | Free | View In iTunes |
|
41 |
Building a M&A Strategy? Do You Have the Right Talent? | Viq Pervaaz, Senior Vice President, Corporate Transactions and Transformation; Pharma Industry Initiative Leader at Aon Hewitt, speaks to Andrea Charles from Pharma IQ, about merger and acquisition activity in the pharmaceutical industry in the& | 8/2/11 | Free | View In iTunes |
|
42 |
Are Orphan Drugs Still a Licence to Print Money? | In this podcast Donald Macarthur, global pharmaceutical business analyst, speaks to Andrea Charles from Pharma IQ, about Pharma's steps into the orphan drug market and whether payers can afford to fund orphan drugs at a time of austerity measures. Mac | 7/20/11 | Free | View In iTunes |
|
43 |
THE ABC to Choosing an ELN | Markus Duerring, IT Account Manager, Novartis Institutes for BioMedical Research, joins Andrea Charles from Pharma IQ, to discuss trends currently shaping the pharma data and knowledge management landscape, key selection crit | 7/20/11 | Free | View In iTunes |
|
44 |
Some Secrets to Success of iPad Application in E-Health | "Most organisations looked at security over the last couple of years and personal devices wouldn’t have been allowed if it’s portable and encrypted. So we’ve turned things around there. Obviously corporate equipment is still encrypt | 7/19/11 | Free | View In iTunes |
|
45 |
One Year On: The Bioequivalence Guidelines | Helmut Schuetz of BEBAC Consultancy and Anders Fuglsang of Fuglsang Pharma Consultancy, join Pharma IQ to discuss the impact of the bioequivalence guidelines introduced in summer 2010 on the pharmaceutical industry. In this debate, we get the views of two | 7/19/11 | Free | View In iTunes |
|
46 |
3 Top Tips for Clinical Trial Supply in India | Gagan Bhradwaj, General Manager-Procurement & Supply Management, Zydus Cadila India, speaks to Andrea Charles from Pharma IQ, about the main challenges for clinical trial supply in Asia now and how the industry is addressing these challenges | 7/18/11 | Free | View In iTunes |
|
47 |
EU: RENEWING HEALTH Update 2011 | Claus Duedal Pedersen, Head of Centre for Clinical Innovation Odense University Hospital speaks to Andrea Charles from Pharma IQ, about effectively utilising telemedicine and increasing pan-European patient-provider cooperation through RENEWING HEALT | 7/7/11 | Free | View In iTunes |
|
48 |
The Potential for EMR to Reduce Medical Errors Needs More Exploration | Healthcare providers across the EU are looking forward to the day when e-health collaboration is a reality and data can flow freely yet securely across institutional and international boundaries. Healthcare IT personnel are working toward t | 7/6/11 | Free | View In iTunes |
|
49 |
Merck Investigates Alternative Strategies: An Interview about DMSO Hydration | The Merck High Throughput Research Facility investigates alternative compound management strategies. One of these is DMSO Hydration. In this Pharma IQ podcast we talk to Ed Hudak, Sr. Research Engineer at Merck & Co., where research is being done to s | 7/6/11 | Free | View In iTunes |
|
50 |
Beyond Informed Consent: New Ethics Protocols for Biobanking | In the context of research involving biobanks , informed consent fails in the two most salient dimensions: in its usual format, informed consent both inhibits important research and yet also fails to protect research participants in some important ways. G | 6/15/11 | Free | View In iTunes |
|
51 |
Critical Success Factors in Patient Safety Strategies | In this Pharma IQ interview Nabil Al-Tawil, Principal Investigator of the Phase I Unit at Karolinska University Hospital, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase 1 clinical development. Al-Tawil explains t | 6/13/11 | Free | View In iTunes |
|
52 |
Troubleshooting Biomarker Development Strategies | In this Pharma IQ interview Kristof Vercruysse, Director Clinical Operations at Ablynx, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase I clinical development and optimisation of biomarker development strategies. | 6/8/11 | Free | View In iTunes |
|
53 |
Using Critical Question Mapping to Structure and Drive Innovation in your Company | An urgent problem facing R&D is the ability to create innovative new products at a cost and speed to market that will accelerate corporate growth. Innovation complexity and the distances and communication barriers that come with globalisation make man | 6/8/11 | Free | View In iTunes |
|
54 |
Improving Paediatric Clinical Trials with Adaptive Design | Dr. Di Wu is the Director of Laboratory for International Research and Relations at Clinical Pharmacology & Therapeutics (CPT) in Children’s Hospital of Philadelphia (CHOP) and a Guest Professor at Central South University & Third Xiangya Ho | 6/7/11 | Free | View In iTunes |
|
55 |
The Peaks and Troughs of Applying New Healthcare Technology | Simon Mortimore, Head of Information Services, University College London Hospitals NHS Foundation Trust, joins Helen Winsor from Pharma IQ, to discuss developments and challenges in e-health and informatics. First, he explains exactly what management info | 6/6/11 | Free | View In iTunes |
|
56 |
3 Ways to Incorporate Adaptive Trials into Your Oncology Drug Development Plans | The lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular tools in oncology research, helping to achieve validity, | 6/6/11 | Free | View In iTunes |
|
57 |
Human Tissue Biobanks: Is it Possible for the Subject to Give Meaningful Informed Consent? | Kieran O’Doherty, PhD, Assistant Professor, University of Guelph, talks to Andrea Charles from Pharma IQ, about ethical, legal, and social issues surrounding biobanks, and how ethical principles prevent or promote the sharing of store | 6/5/11 | Free | View In iTunes |
|
58 |
The Rise of Academic/Industry Collaboration in Amorphous Material Studies | Marc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the use of amorphous pharmaceutical materials to impr | 5/31/11 | Free | View In iTunes |
|
59 |
Sharpen up on Patient Self-Management Approaches | Soren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Helen Winsor from Pharma IQ, to discuss best practice approaches to patient education and self management. Firstly, Skovlund talks about how NovoNordisk approaches th | 5/30/11 | Free | View In iTunes |
|
60 |
Utilising DMAIC for Regulatory Decision Cycle Time Optimisation | According to FDA guidelines for medical device manufacturers, decision making for reportability purposes to regulatory authorities is required within 30 days of a potential complaint reception. In this podcast, Sebastian Fishman, Project Coordinator at Al | 5/30/11 | Free | View In iTunes |
|
61 |
How Pfizer Approaches Compound Management and the Changing Role of CROs | The role of CRO s in the drug discovery process is constantly evolving, and as data management and distribution efforts improve, there is increased opportunity for leveraging CROs within Drug Discovery research. In this podcast, Rose Gonzales, Director at | 5/30/11 | Free | View In iTunes |
|
62 |
How can Pharma Distribution Make an Impact in the Boardroom? | Frank Binder, Director of International Logistics and Supply Chain at Celgene, joins Helen Winsor at Pharma IQ, to discuss how pharmaceutical distribution can add more value to business. Firstly, he discusses the importance of the ‘last mile’& | 5/18/11 | Free | View In iTunes |
|
63 |
30% of Diabetes Patients Admit Skipping Insulin Injections | Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics, adolescents and adults. In this exclusive interview,  | 5/18/11 | Free | View In iTunes |
|
64 |
A Direct Route to an Optimum Sponsor/Vendor Partnership | Steve Jacobs, Chair of the Global Clinical Suppliers Group and President of Global BioPharm Solutions, joins Helen Winsor from Pharma IQ, to discuss how to go about creating the best sponsor/vendor partnership and how to balance cost versus service. He al | 5/11/11 | Free | View In iTunes |
|
65 |
Stumbling Blocks for Patient Compliance in Parkinson’s Disease Treatment | Nicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers. He also outlines the best strategy for success in increasing adheren | 5/11/11 | Free | View In iTunes |
|
66 |
Using SharePoint as an Electronic Laboratory Notebook; and Interview with Tina Spendler | In this Pharma IQ interview, Tina Spendler, Project Manager at Novozymes, talks to John Trigg , Director of phaseFour Informatics. Spendler explains the background to Novozymes' decision to use SharePoint as the platform for their ELN . She also talks | 5/9/11 | Free | View In iTunes |
|
67 |
Don’t Get Lost in Translation – Reflections on Pharmaceutical Labelling | Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in lab | 5/8/11 | Free | View In iTunes |
|
68 |
Choosing a New CMO? The Cost of Change is Critical | Richard Loughlin, Director, Contract Manufacturing Business Development North America, Commercial & External Partnerships (CEPiA) sanofi aventis, joins Andrea Charles from Pharma IQ, to discuss contract manufacturing trends and the a dvantag | 5/2/11 | Free | View In iTunes |
|
69 |
Advice for Pharmaceutical Process Improvers: Think First, Do Later | Want to improve a process? Start off by thinking of all the reasons why you shouldn't. That's one of the lessons learned by Brian Eden, Global Head of Operational Excellence at Mylan Laboratories. In this podcast, Eden discusses ways of | 4/20/11 | Free | View In iTunes |
|
70 |
Do You Know How to Integrate the Semantic Capabilities of Your ELN? | In this exclusive Pharma IQ interview, Jeremy Frey, Professor of Physical Chemistry at the University of Southampton, joins John Trigg, Director of phaseFour Informatics, to discuss increasing the semantic capabilities of your ELN to capture more com | 4/18/11 | Free | View In iTunes |
|
71 |
8 Social Media Recruiting Strategies for Identifying and Recruiting Top Talent in Healthcare | “Tweet, tweet, tweet…” If a bird is the only thing that comes to mind, then you’ve yet to jump on the social networking bandwagon. Twitter, Facebook and LinkedIn are just a few of the social media tools making their voices heard i | 4/12/11 | Free | View In iTunes |
|
72 |
What’s New in Lab Data and Information Management? | Burkhard Schaefer, head architect at AnIML, BSSN Software joins John Trigg, director and founder of phaseFour-informatics to discuss the AnIML project and advances in Laboratory Data and Information Management. Haven’t got the technology to listen t | 4/12/11 | Free | View In iTunes |
|
73 |
Measuring Solubility – Pitfalls to Avoid for Better Efficiency | Dr. Jonathan Goodman, Lead Professor at the University of Cambridge, joins Helen Winsor from Pharma IQ, to discuss competitive solubility measurements: implementing the right measurements for your solubility strategy. Dr. Goodman outlines the main approac | 4/10/11 | Free | View In iTunes |
|
74 |
Using New Media to Improve the Output of Pharmacovigilance Data | Shaloo Pandhi, Group Head Pharmacovigilance Operation, Novartis Healthcare, India, talks to Andrea Charles from Pharma IQ, about risk management strategies and optimising drug safety activities. Pandhi also discusses the advantages of utilising | 4/4/11 | Free | View In iTunes |
|
75 |
Conducting Adaptive Trials in Global Settings | Conducting a trial with adaptive design poses unique challenges when conducted in an international setting. There are complex regulatory, logistical, financial, and project management issues that exist for multinational trials. In this podcast, Dr. Mukesh | 4/4/11 | Free | View In iTunes |
|
76 |
Compliance Packaging, Walmart and Improving Patient Outcomes | According to Freedonia's US Pharmaceutical Packaging Market report, demand for pharmaceutical packaging is projected to grow in the US to $18.4 billion by 2014. In this interview Charles Aubrey, Vice President at Anderson Pharmaceutical Pack | 4/3/11 | Free | View In iTunes |
|
77 |
The Dark Side of Globalisation: Conquering Counterfeit Medicine Now Requires a Global Solution | Part of the impact of the globalisation of the pharmaceutical industry has been an increase in the volume of counterfeiting and the level of sophistication. In this podcast Jeffrey Gren, Director of the Office of Health and Consumer Goods, joins Phar | 4/3/11 | Free | View In iTunes |
|
78 |
Are You Uncertain About GPCM Integration? | Dr. Rainer Beck, External Supply Organisation, Supply Relationship Manager, Novartis Pharma AG, joins Helen Winsor from Pharma IQ, to discuss the changing domain of global pharmaceutical contract manufacturing as pharma companies increasingly integrate th | 3/30/11 | Free | View In iTunes |
|
79 |
Building a Compound Management Facility – The Integration Challenge | Reiner Dieden PhD, Analyst and Physical Chemistry and Logistics Director from UCB, joins Helen Winsor Pharma IQ, to report on the development of a compound management facility at The University of Bonn. He discusses the challenges faced by the Neuro | 3/30/11 | Free | View In iTunes |
|
80 |
Biobanking: Moving Towards Prospective Procurement | Jon Wetzel, Founder of the Lean for Everyone Blog, joins Andrea Charles from Pharma IQ, to discuss recent technological and commercial trends in the biobanking sector. Wetzel offers his experience in implementing lean methodologies and | 3/30/11 | Free | View In iTunes |
|
81 |
Saving Time and Money with Transporter Studies | Dominic Surry, Associate Director of In Vitro Screening & Profiling at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss clinically relevant drug transporters. He explains the importance of exploring and understanding the forthcoming FDA/EMA | 3/28/11 | Free | View In iTunes |
|
82 |
Tips to Get to Grips with the CDISC Mindset | Peter Van Reusel, Business Unit Director of CRO Services at Business & Decision Life Sciences, and Albert Chau, Director of Datacision, join Helen Winsor from Pharma IQ to discuss CDISC standardisation. They debate whether there are any viable al | 3/27/11 | Free | View In iTunes |
|
83 |
Top Trends Shaping Pharma Data and Knowledge Management | Terry Murphy, Director Systems Implementation, Strategic Operations, PDMS, Janssen Pharmaceutical Companies of Johnson & Johnson, joins Andrea Charles from Pharma IQ, to discuss the top trends shaping pharma data and knowledge management, the main hur | 3/27/11 | Free | View In iTunes |
|
84 |
How to Avoid Common Pitfalls in the Design of Medical Interfaces | Human factors principles and practices are playing an increasingly important role in medical device design as manufacturers recognise the range of benefits. In this interview Dr. Edmond W Israelski, Director, Human Factors, Abbott Quality and Regulatory, | 3/22/11 | Free | View In iTunes |
|
85 |
Pharmacovigilance is Not Just About Compliance | Dr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to report adverse drug events (ADEs) and how understanding | 3/22/11 | Free | View In iTunes |
|
86 |
Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market | Eric S. Langer, Managing Partner, BioPlan Associates, joins Andrea Charles from Pharma IQ, to address how the contract manufacturing sector is adapting to the changing needs of pharma and biotech, the need for access to enabling technologies and how | 3/20/11 | Free | View In iTunes |
|
87 |
Software Quality for Safety Critical Products | Software quality for safety critical products has been at the centre of discussion for industry experts and the FDA. Many problems are due to software malfunctions. In this podcast, Thuy Cook, Senior Software Quality Engineer for Covidien, discusses how t | 3/16/11 | Free | View In iTunes |
|
88 |
Setting Standards for Proactive Pharmacovigilance in India | With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the in | 3/16/11 | Free | View In iTunes |
|
89 |
3 Top Security-Enhancing Tips for Reducing Cargo Thefts | Barry Tarnef, Assistant Vice President, Senior Loss Control Specialist, Chubb & Son, speaks to Andrea Charles from Pharma IQ, about current risk management trends in the supply chain for biologicals and biological agents, the challenges of&n | 3/14/11 | Free | View In iTunes |
|
90 |
Why Changes are needed to Current Preformulation and Formulation Practices | As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ , about why changes are needed to current preformulation and formulation pract | 3/14/11 | Free | View In iTunes |
|
91 |
Has Your Supply Chain Had a Health Check Recently? | Reliable, on-time delivery and distribution are vital components of a healthy supply chain. Streamlining distribution processes while improving quality and lowering costs are all key. Evaluating one’s operations is the starting point. Tod | 3/9/11 | Free | View In iTunes |
|
92 |
Spray-Dried Dispersion Technology: Solving Drug Solubility Challenges | Amorphous spray dried dispersions (SDDs) have emerged as a broadly applicable technology for the delivery of poorly soluble drug molecules. Methods for formulating and predicting the physical stability of these formulations are becoming better understood | 3/9/11 | Free | View In iTunes |
|
93 |
Fighting Counterfeit Medicines: What's Next? | Jim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ to discuss pharmaceutical counterfeiting, new EU legislation and EAASM’s recommendations. | 3/7/11 | Free | View In iTunes |
|
94 |
What Are the Advantages and Disadvantages of Human Embryonic Kidney (HEK) Cells for the Analysis of Uptake Transporters? | Dr. Jörg König from the Institute for Experimental and Clinical Pharmacology and Clinical Toxicology at Friedrich-Alexander-University Erlangen-Nürnberg, Germany , speaks to Rebecca Maschke from Pharma IQ, about the analysis of transporter- | 3/3/11 | Free | View In iTunes |
|
95 |
Speeding the Evaluation of New Drugs and Technologies for the Paediatric Population | Dr. Gonzalo de Miquel, Director, Respiratory Therapy Area at Almirall R&D, speaks to Andrea Charles from Pharma IQ, about the enigma of paediatric research. In this podcast de Miquel discusses the key components of a good paediatric st | 3/3/11 | Free | View In iTunes |
|
96 |
Adverse Immune Effects of Nanomedicines and Biologicals– Under the Microscope | Janos Szebeni, Director of the Nanomedicine Research and Education Center, Bay Zoltan Foundation for Applied Research at Semmelweis University, Budapest, joins Helen Winsor Pharma IQ, to discuss developments in immunogenicity. In this exclusive interview, | 3/1/11 | Free | View In iTunes |
|
97 |
Avoiding FAA Fines Amidst Increasing Scrutiny and Changing Regulations | A changing regulatory landscape and increased scrutiny is an unavoidable reality within the pharmaceutical and biotech industries. A constant reanalysis of regulations is crucial for all manufacturers. Michael Burdick, Special Agent, Security and Hazardou | 2/27/11 | Free | View In iTunes |
|
98 |
How to Succeed in Patient Recruitment and Retention | Stig Moller Christensen, International Planning and CRO Manager at ALK-Abelló, joins Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, to discuss patient recruitment & retention strategies. He outlines the most crucial factors for pivotal studie | 2/23/11 | Free | View In iTunes |
|
99 |
iPad Informatics: Achieving Interoperability | Chris Archer from Pharma IQ, speaks exclusively with Terrell Herzig, Adjunct Professor of Health Informatics, University of Alabama at Birmingham, UAB Health System. The interview explores how the UAB laboratory has implemented iPad technology and how thi | 2/22/11 | Free | View In iTunes |
|
100 |
Is the European Harmonisation of HTA Worth Pursuing? | Ansgar Hebborn, Head of the Global Payer & HTA Program Policy at F Hoffmann-La Roche, joins Tim Haïdar from Pharma IQ, to analyse major trends and implications for the research-based pharmaceutical industry. Firstly he sums up who decid | 2/22/11 | Free | View In iTunes |
|
101 |
Big Formulation Breakthroughs | David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the most critical unmet drug delivery need and the benefits of early formulation testing. Elder shares | 2/16/11 | Free | View In iTunes |
|
102 |
Building Strategic Partnerships and Alliances | Larry Blankstein, Sr. Director Clinical Research at Genzyme, joins Andrea Charles from Pharma IQ, to discuss resource management and clinical outsourcing. Blankstein talks about the challenges he faces in his clinical outsourcing today and | 2/8/11 | Free | View In iTunes |
|
103 |
Three Top Tips for Optimising Physical Form Selection | What strategies are pharmaceutical companies employing to accelerate early development and preformulation? Michael Mitchell, Head of Pharmaceutical Sciences Oss, Merck, speaks to Andrea Charles from Pharma IQ, about current preformulation strategies | 2/8/11 | Free | View In iTunes |
|
104 |
Oral Lipid Formulations - Enhancing the Bioavailability of Poorly Water Soluble Drugs | Lipid formulations have gained momentum in recent years as an efficient means for improving solubility of new chemical entities, but ensuring the stability of these systems can prove challenging. Dr. David Hauss, Principal of Hauss Associates, has written | 2/2/11 | Free | View In iTunes |
|
105 |
How to Avoid Common Pitfalls in Formulation | Outsourcing various elements of formulation work has obvious advantages, but there are also some common pitfalls. Martin Schubert, Formulation Group Leader at UCB, joins Helen Winsor from Pharma IQ, to discuss developments and challenges in formulation.&n | 2/1/11 | Free | View In iTunes |
|
106 |
Next Steps to Treat Parkinson’s, Huntington’s and Alzheimer’s Disease | Joachim Tedroff, Head of Clinical Science at NeuroSearch Sweden AB, joins Helen Winsor from Pharma IQ, to discuss strategies for optimising clinical development in CNS. First Tedroff outlines what he sees as the major challenges in the development of  | 1/31/11 | Free | View In iTunes |
|
107 |
Protect and Shield: RF Wireless Technology in Medical Devices | As more medical devices incorporate flat flexible cables (FFC), polymer thick film circuits (PTF), and flexible printed circuits (FPC), what can engineers do from an interference perspective? Glen Griffith, Principal RF Communication Engineer, Alfred Mann | 1/26/11 | Free | View In iTunes |
|
108 |
Which Types of Biomarkers Truly Benefit AD? | Johannes Streffer, Director, Experimental Medicine Europe, Janssen Research & Development, Janssen Pharmaceutica NV, speaks to Andrea Charles from Pharma IQ, about where he feels the focus really lies at the moment for experimental medicine | 1/24/11 | Free | View In iTunes |
|
109 |
What Opportunities will Drive Global Expansion and Growth for Indian Pharmaceuticals? | As part of the Pharma Leaders Today Series Dr. Akhilesh Sharma, Senior Vice President, Clinical (R&D), Piramal Life Sciences, speaks to Andrea Charles from PharmaIQ, about the unique challenges facing the Indian clinical R&D market and | 1/24/11 | Free | View In iTunes |
|
110 |
Fälschungssicherheit & Blindenschrift: Was bringt die Zukunft? | In diesem Podcast spricht Thomas Brückner, Leiter des Geschäftsfeldes Pharmazie, Besondere Therapierichtungen und Medizinprodukte bei der Bundesverband der Pharmazeutischen Industrie e.V., über die Herausforderungen, die mit den Regelungen | 1/20/11 | Free | View In iTunes |
|
111 |
Do You Know Enough About Next-Generation DNA Sequencing in Cancer? | Elia Stupka, Scientific Director of Bioinformatics at UCL Genomics, joins Helen Winsor form Pharma IQ, to discuss next-generation DNA sequencing and recent developments in next-generation sequencing technologies. Stupka also shares his insights on bu | 1/19/11 | Free | View In iTunes |
|
112 |
Should Pharma Focus on New Chemical Entities to Avoid Patent Challenge? | As part of the new Pharma Leaders Today series, Philip C. Strassburger, V.P., Intellectual Property Counsel at Purdue Pharma, spoke to Andrea Charles from Pharma IQ, about what trends he is currently seeing in pharmaceutical and biotec | 1/19/11 | Free | View In iTunes |
|
113 |
Top Tips on Assessing Molecular Systems of Response | Karol Sikora Medical Director at CancerPartners UK, joins Helen Winsor from Pharma IQ, to discuss new trial design approaches and biomarker application methods coming on stream to drive oncology clinical development. The main focus of this exclusive inter | 1/18/11 | Free | View In iTunes |
|
114 |
The Problem of Patent Trolls – What Can We Do? | Peter Kjaer, Head of Patents at Lego, joins Helen Winsor from Pharma IQ, to discuss intellectual property right trends in the Nordic region. With patent trolls still a key concern, Kjaer explains why these provide an ongoing threat and why companie | 1/18/11 | Free | View In iTunes |
|
115 |
Nanocluster Technology and Microcapsule Approaches: Two New Drug Delivery Mechanisms | New techniques for developing drug delivery mechanisms have led to two new particle engineering approaches that offer unique formula opportunities. Dr. Cory Berkland, Associate Professor at the University of Kansas, joins Amber Scorah from Pharma IQ, | 1/16/11 | Free | View In iTunes |
|
116 |
Best Practice Tips for Successful eCTD Submissions | Yann Kervevan, EMEA Regulatory Affairs Operations Manager, Alexion Pharmaceuticals, joins Helen Winsor from Pharma IQ, to dicsuss the challenges in eCTD implementation and electronic submissions. Firstly Kervevan offers some best practice tips for industr | 1/13/11 | Free | View In iTunes |
|
117 |
Implementing Global Techniques and Developing a Framework to Accelerate the Clinical Trials Process | Dr. Rajendra Jani, Senior Vice President and Head of Clinical R&D, Cadila Healthcare , joins Andrea Charles from Pharma IQ, to discuss how to increase the efficiency of your clinical trials whilst retaining quality and current trends for clinical tria | 1/12/11 | Free | View In iTunes |
|
118 |
Tips and Tatics for Navigating the Antitrust Landscape | As part of the new Pharma Leaders Today series, Allen E. Norris, Vice President and Head Group IP at UCB Pharma, speaks to Andrea Charles from Pharma IQ, about current trends in biopatents and how pharma companies can readdress the imb | 1/12/11 | Free | View In iTunes |
|
119 |
Spearheading Economically Sustainable Scientific Strategies for Cancer | Prof. Dr. Ahmed Elzawawy, President of International Campaign for Establishment and Development of Oncology Centres (ICEDOC) & Co-President of South and East Mediterranean College of Oncology ( SEMCO), speaks to Andrea Charles from P | 1/11/11 | Free | View In iTunes |
|
120 |
Developing Strategies and Tactics for Biobanking in a Healthcare System | Dr. Walter Stewart, Associate Chief Research Officer at Geisinger Center for Health Research, joins Andrea Charles from Pharma IQ, to discuss how biobanking can be leveraged to improve healthcare delivery. Stewart also shares his insights on the cha | 1/11/11 | Free | View In iTunes |
|
121 |
The Do’s and Don’ts of Process Validation | Stephen Brown, CTO of Vivalis and a Member of the Single Use Task Force, PDA, joins Helen Winsor from Pharma IQ, to discuss the application of risk management strategies when implementing single-use systems (SUS). First Brown outlines how best to imp | 1/11/11 | Free | View In iTunes |
|
122 |
Offshoring of R&D to Asia | Dr. Frank Floether, Ex Vice-President Business Development Asia Pacific for Johnson and Johnson, speaks to Andrea Charles from Pharma IQ, about the common mistakes pharmaceutical companies make when entering emerging markets and his top 3 tips | 1/11/11 | Free | View In iTunes |
|
123 |
Optimising Your Pharmacovigilance Activities in Clinical Trials | Pharmacovigilance is an important and integral part of clinical research . Elie Magdalani, Regional Manager, Medical and Pharmacovigilance Affairs Egypt and North Africa, Ranbaxy Egypt, joins Andrea Charles from Pharma IQ, to talk about how we can en | 1/10/11 | Free | View In iTunes |
|
124 |
Should We Follow Apple's Example When Designing Medical Devices? | In this exclusive interview Sean Fenske, Editor-in-Chief for Medical Design Technology (MDT), speaks to Chris Archer from Pharma IQ, about the rapid adoption of medical electronic devices in an ever changing environment and overcoming | 1/9/11 | Free | View In iTunes |
|
125 |
Achieving the 4 Rights in Effective Health Care: An Interview with Peter Pitts | As part of the new Pharma Leaders Today series, Peter Pitts, President and co-founder of the Center for Medicine in the Public Interest and Partner/Director Global Healthcare, Porter Novelli, spoke to Andrea Charles from Pharma IQ, about the&nbs | 1/6/11 | Free | View In iTunes |
|
126 |
Cutting Attrition Rates in Your CNS Clinical Trials | Dr. Wolfgang Eglmeier, Head of Clinical Operations Germany, Grünenthal GmbH, joins Helen Winsor from Pharma IQ, to discuss optimising clinical development in CNS. He outlines the main challenges when recruiting for CNS trials and some strategies that | 1/6/11 | Free | View In iTunes |
|
127 |
How to Deliver Safer, More Efficacious Drugs to Market with Algorithmic Systems and In Silico Technologies | Corrado Priami, CEO and President of CoSBi (Centre for Computational and Systems Biology), joins Helen Winsor from Pharma IQ, to talk about how we can ensure the delivery of safer and more efficacious drugs to market with algorithmic systems and in-silico | 1/3/11 | Free | View In iTunes |
|
128 |
Panel Predicts Future of Smart Labs | Enhancing laboratory innovation and automation can minimise compliance risk and improve workflow from lab bench to product release. In this exclusive Pharma IQ panel discussion, in conjunction with the 2011 Smart Lab Exchange, John Helfrich, Vic | 1/3/11 | Free | View In iTunes |
|
129 |
Improving PAT Validation | Qualification of equipment and validation of analytical methods are critical components for the implementation of process analytical technology (PAT). Martin Warman, Scientific Fellow, Analytical Development at Vertex Pharmaceuticals, joins Andrea Charles | 12/23/10 | Free | View In iTunes |
|
130 |
Providing Compliant Regulatory Submissions | Mickel Hedemand, Internal Advisor, Licensing Division at the Danish Medicines Agency, spoke to Andrea Charles from Pharma IQ, about the commonest reasons why companies fail first time submission and the challenges of developing globall | 12/23/10 | Free | View In iTunes |
|
131 |
Improving Bioavailability with Novel Drug Delivery Solutions | Toxicology formulation is an essential component of drug development. Dr. Chong-Hui Gu, Associate Director at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discusss how novel formulation technologies can solve the exposure | 12/21/10 | Free | View In iTunes |
|
132 |
German Customs – Cracking Down on Pharma Counterfeiting | Dirk Schaub, IP Crime Investigator at Germany Customs, joins Helen Winsor from Pharma IQ, to discuss challenges and recent developments in anti-counterfeiting. He highlights the main threats facing the industry at the moment, his ideas on preventative act | 12/19/10 | Free | View In iTunes |
|
133 |
Have Your Oncology Trials Got Their Running Shoes? | Oncology is the largest investment area for the pharmaceutical industry, as a result there is a great deal of competition between key players and emphasis on speeding time to market. Benedikte Thunes Akre, Scientific Advisor - Oncology at Bristo | 12/19/10 | Free | View In iTunes |
|
134 |
Delivering Patient Compliance Through User Focused Development of Delivery Systems | Tim Chesworth, Team Manager - Packaging & Devices at AstraZeneca, joins Andrea Charles from Pharma IQ, to speak about delivering patient compliance through user focused development of delivery systems. Chesworth discusses the key drive | 12/19/10 | Free | View In iTunes |
|
135 |
Celgene's Expansion into Asia | Dr. Frank Binder, Director, International Logistics & Supply Chain at Celgene, joins Andrea Charles from Pharma IQ, to discuss the key considerations for selecting business models across Asia and how to choose the right partners for local distrib | 12/16/10 | Free | View In iTunes |
|
136 |
Delivering the Best Drugs to Market – With Companion Diagnostics | Mads Ropke, Senior Scientist at LEO Pharma, joins Helen Winsor from Pharma IQ to discuss companion diagnostics and how we can ensure the delivery of safer and more efficacious drugs to market. First, he outlines how companion diagnostics can help us to ad | 12/16/10 | Free | View In iTunes |
|
137 |
Rules of Thumb for Pharmaceutical Information Management | Alastair Scarlett, Regulatory Operations Project Manager at UCB Pharma, joins Helen Winsor from Pharma IQ to discuss developments in regulatory information management (RIM). In this exclusive interview, Scarlett takes a look at key innovations in the pipe | 12/15/10 | Free | View In iTunes |
|
138 |
The Importance of Pharmacogenomics in the Context of Biobanking | Dr. Lynn Dressler, Assistant Professor at the Eshelman School of Pharmacy and Associate Director for Policy and Ethics at the Institute for Pharmacogenomics and Individualised Therapy at the University of North Carolina, Chapel Hill, joins Amber Scorah fr | 12/14/10 | Free | View In iTunes |
|
139 |
Ways to Efficient Container Closure Testing Systems | Dr. Caspar Schatz, Manager for Optical, and In Process Control, Roche Diagnostics GmbH, joins Helen Winsor from Pharma IQ, to discuss developing and evaluating container closure testing systems. Schatz outlines the different approaches to monitoring syrin | 12/14/10 | Free | View In iTunes |
|
140 |
Green Biobanks and Non-Invasive Sampling Techniques | Biobanks are not immune to the pressure to use 'green' technology. Traditional storage facilities require samples to be maintained at −80 °C. In this Pharma IQ podcast Dr. Michael Scheurer, Assistant Professor and Director of the Populat | 12/13/10 | Free | View In iTunes |
|
141 |
How to Overcome Challenges with siRNA Targeting | Professor Ann Logan, Lead Professor, University of Birmingham, joins Helen Winsor Pharma IQ, to discuss next-generation DNA sequencing. Logan reports on her laboratory’s primary research into the role of the intravitreal inflammation in the axo | 12/12/10 | Free | View In iTunes |
|
142 |
A Comparative Analysis of Single-Use Bioreactors – The Results | Aurore Poles Lahille, Assistant Scientist and Specialist in New Technologies and Manufacturing Support at Merck Serono Biodevelopment, joins Helen Winsor from Pharma IQ, to discuss a comparative analysis of single use bioreactors and understanding the mos | 12/12/10 | Free | View In iTunes |
|
143 |
Trying to Stay Cool: Canadian Pharmacy Players Under Pressure from Changes to Generic Pricing | Joe Knott, Managing Director of the Pangaea Group, joined Andrea Charles from Pharma IQ, to discuss the dramatic changes to the Canadian drug distribution market in recent years. Knott shares his top tips for a company choosing a distribution mo | 12/7/10 | Free | View In iTunes |
|
144 |
Expert Tips in Freeze Dryer Cleaning and Validation | Kevin Murgatroyd, Senior Pharmaceutical Consultant and expert in the field of cleaning and validation of freeze dryers, joins Helen Winsor from Pharma IQ, to discuss lyophilisation in biologicals. Murgatroyd looks at the key criteria when cleaning freeze | 12/6/10 | Free | View In iTunes |
|
145 |
Generating Metabolically Active Hepatocytes from Pluripotent Stem Cells | Dr. David Hay, Principal Investigator at the MRC Centre for Regenerative Medicine, joins Helen Winsor from Pharma IQ, to discuss the challenges and potential of metabolically active hepatocytes, covering the following areas: Insights into polymer screenin | 12/6/10 | Free | View In iTunes |
|
146 |
Inside Tips on Making Progress in PAT | Rakhi Baj, Technical Project Leader at Abbott Diagnostics, joins Helen Winsor from Pharma IQ, to offer some best practice ways to overcome common challenges in PAT. Baj talks about her background in the area and the work she is cu | 12/6/10 | Free | View In iTunes |
|
147 |
The Convergent Lab: Accelerating Discovery by Enhancing Data and Information Integration | Ralph Haffner, Head of Biologics Research Informatics at Roche, spoke to Andrea Charles from Pharma IQ, about the challenges of achieving seamless integration between ELNs, LIMS and other IM systems and how the industry is addressing these chall | 12/5/10 | Free | View In iTunes |
|
148 |
Is Predictive Toxicology the Fast Track to Safe Drugs? | Unexpected toxicity is the single biggest cause of pipeline attrition. Dr. Thomas Steger-Hartmann, Head of Investigational Toxicology at Bayer Healthcare, spoke to Andrea Charles from Pharma IQ, about the strategies m edicinal chemists are increasing | 12/1/10 | Free | View In iTunes |
|
149 |
What Impact is Lead-Time Reduction Having on the End-to-End Pharma Supply Chain? | Antoine du Sartel, Director of Global Supply Chain at Merck Serono, speaks to Andrea charles from Pharma IQ, about the impact lead-time reduction is having on the end-to-end pharma supply chain and the steps we should take to ensure end-to- | 11/29/10 | Free | View In iTunes |
|
150 |
What is the Significance of the Max Inventory Point? | In this German Language interview, Angelika Kemser-Schmid, Logisitic and Warehouse Manager at Orthofix GmbH, speaks to Rebecca Maschke from Pharma IQ, about her company’s CIC Project and explains how the Max Inventory Point can contribute to invento | 11/29/10 | Free | View In iTunes |
|
151 |
Utilising Accelerated Degradation Studies to Better Predict Product Stability | Dr. Paul Matejtschuk Principal Scientist at NIBSC, joins Andrea Charles from Pharma IQ, to address the key challenges in optimal formulation development and how advances in freeze drying have impacted on formulation development. Matejtschuk also dicu | 11/25/10 | Free | View In iTunes |
|
152 |
Message from the Regulators: Pharmacovigilance to Move Heavily into Risk-Benefit Assessment | Pilar Carrero Director of Safety Medical Writing at Novo Nordisk, joins Andrea Charles from Pharma IQ, to discuss the impact social media has had on drug safety and risk managment and the dawn of a new era for pharmacovigilance. Carrero also shares h | 11/24/10 | Free | View In iTunes |
|
153 |
Industry View: Consequences of the New Variations Regulation for the ECTD | Electronic submissions can substantially reduce submission time, allowing for a quicker release of products onto the market. However, the implementation and handling of eCTD can be problematic due to different standards at each European agency. In th | 11/24/10 | Free | View In iTunes |
|
154 |
Combatting Software Compromise of Implantable Medical Devices | Srdjan Capkun, Assistant Professor at the Swiss Federation Institute of Technology, joins Helen Winsor from Pharma IQ, to discuss securing access and reprogramming of medical devices. In this interview Capkun defines the problem of secure access and repro | 11/18/10 | Free | View In iTunes |
|
155 |
Freeze-Drying, Formulation and the Future of Lyophilisation | In this interview Helen Winsor from Pharma IQ, speaks to lyophilisation expert, Michael Pikal, Professor of Pharmaceutics at the University of Connecticut, who has dedicated his life’s work to freeze drying. Pikal sheds light on this complex field, | 11/17/10 | Free | View In iTunes |
|
156 |
Lean Innovation: Buzzword or Feasible Phenomenon? | Celia Banks, R&D and Medical BT CI Lead at Pfizer, joins Helen Winsor from Pharma IQ, to discuss whether Lean innovation is the non sequitur it seems, or actually a real possibility. Banks offers some step-by-step pointers on how it can be embedd | 11/16/10 | Free | View In iTunes |
|
157 |
From Tactical to Strategic Partnerships: Establishing Efficient Discovery Outsourcing Strategies | Effective partnerships can play a vital role in the drug discovery process and can contribute to an enhanced product pipeline and increased profitability. In this interview Richard Morphy from the Medicinal Chemistry Dept at the Scheri | 11/10/10 | Free | View In iTunes |
|
158 |
Adaptive and Group Sequential Clinical Methods for Clinical Trial Design | Chris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how important group sequential design is to clinical trials.&n | 11/10/10 | Free | View In iTunes |
|
159 |
Transforming Biomanufacturing with Single-Use Systems | In this interview Jerold Martin, Sr. V.P., Global Scientific Affairs, Biopharmaceuticals, Pall Life Sciences and Chairman of the Board and Technology Committee at the BPSA, speaks to Andrea Charles from Pharma IQ, about future trends for Single-Use b | 11/7/10 | Free | View In iTunes |
|
160 |
Combating Resistance in Antibiotic Drug Discovery and Development | The epidemiology of increasing resistance problem continues to garner much attention. A bacteria capable of opposing the inhibitory (bacteriostatic) or killing (bacteriocidal) effects of antibiotics has unfortunately become an increasingly common occurren | 11/1/10 | Free | View In iTunes |
|
161 |
Labelling Compliance for Medical Devices: Wanted Global Harmonisation! | Peter Schroeer, Director Europe, Quality Systems & Regulatory Affairs at Johnson & Johnson, speaks to Andrea Charles from Pharma IQ, about the current compliance challenges the medical device market faces and what impact the r | 11/1/10 | Free | View In iTunes |
|
162 |
Has the Balance of Power Shifted Along the Clinical Supply Chain? | Steven A. Jacobs, President, Global BioPharm Solutions, shares his insights with Andrea Charles from Pharma IQ, about the paradigm shift in pharma and how this will this directly affect the clinical trial supply area. Jacobs also speaks about the mov | 10/28/10 | Free | View In iTunes |
|
163 |
Establishing Predictive Models to Guide and Optimise the Development of Formulas | Cornelius Pompe, Head of Freeze Dried Product Development at LFB Technologies, speaks to Andrea Charles from Pharma IQ, about the key drivers of the lyophilisation market and shares his insights on how advances in freeze drying have impacted on | 10/27/10 | Free | View In iTunes |
|
164 |
Biobanking: Truth and Transparency | Public awareness of biobanking is growing and lack of transparency can lead to closure of a biobanking project. David Kaufman, Director of Research and Statistics Genetics and Public Policy Center, John Hopkins University, speaks to Andrea Charles fr | 10/21/10 | Free | View In iTunes |
|
165 |
Viral Safety: The AFSSAPS Speaks Out About the Regulatory Environment | Contaminations in biological products in 2009 and the porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year has highlighted the issue of viral safety in biologics more than ever before. Marc Martin, Viral Safety Assessor at | 10/20/10 | Free | View In iTunes |
|
166 |
Keeping Your Supply Chain Competitive: Priorities for 2011 | Paul Wiberg-Jørgensen, VP Logistics, Statens Serum Institut, speaks with Andrea Charles from Pharma IQ, about recent European supply chain trends and how the landscape is evolving to meet the needs of the pharmaceutical industry. In this inte | 10/13/10 | Free | View In iTunes |
|
167 |
How to Sustain Effective Continuous Improvement in Your Organisation | Lean principles drive cost reduction, improve efficiency and increase ROI. In this podcast, Elisabeth Goodman, former Business Operations Consultant, GlaxoSmithKline and Owner of RiverRhee Consulting, speaks to Andrea Charles at Pharma IQ, about the uniqu | 10/7/10 | Free | View In iTunes |
|
168 |
Challenges and Opportunities in the Use of Biomarkers in Early Phase Trials | In this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development, a t which points they should be utilised and how. J | 10/6/10 | Free | View In iTunes |
|
169 |
What are the Requirements for Establishing a Data Network Collaboration? | In this interview Jos van den Heuvel, Director of External Manufacturing at Janssen Pharmaceutica NV, Johnson & Johnson, speaks to Rebecca Maschke from Pharma IQ, about supplier integration and the advantages of establishing a data network c | 10/4/10 | Free | View In iTunes |
|
170 |
The Calm Before the Storm: Preparing for the EU Pharma Package | Jim Thomson, Chair of the European Alliance for Access to Safer Medicines (EAASM), discusses the implications of the EU Pharma package with Helen Winsor from Pharma IQ. Thomson explains how pharmaceutical packaging and anti-counterfeiting measures have ch | 9/28/10 | Free | View In iTunes |
|
171 |
How to Address the IP Issues Specifically Associated with Polymorphic Forms | It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intr | 9/28/10 | Free | View In iTunes |
|
172 |
What is the Goal of the Budni-Partner-Pharmacies Project? | In this German-speaking interview, Jens Apermann, CEO of Iwan Budnikowsky Marketing GmbH, gives insight into his company’s marketing and selling of non-prescription pharmaceutical products outside the traditional German pharmacy setting. | 9/22/10 | Free | View In iTunes |
|
173 |
Adaptive Design, Often Maligned | When carried out well, adaptive trials not only provide evidence of safety and efficacy more quickly, but also allow you to assess that evidence and get answers earlier. In this interview John Johnson, Senior Biostatistician at Cato Researc | 9/21/10 | Free | View In iTunes |
|
174 |
Meet Your Goals: Choose the Right Partner and Cut Costs | Patrice Talaga, Director of Chemistry Outsourcing at UCB, shares his experience of early alliance partnerships between academia and pharmaceutical companies, in this exclusive interview with Helen Winsor from Pharma IQ. Talaga outlines the main chal | 9/15/10 | Free | View In iTunes |
|
175 |
Ensuring In-House Audit Programmes are Strategically Focused through Implementing Risk Models | 20% of all clinical trials are now subject to regulatory audits! With inspectors’ expectations continually evolving and an increasing number of regulatory warnings, relating to record keeping and informed consent, it is more important than | 9/9/10 | Free | View In iTunes |
|
176 |
Improving Pharmaceuticals Through Co-Crystals | In this podcast Dr. Nair Rodriguez-Hornedo, Professor, Department of Pharmaceutical Sciences at the University of Michigan, s peaks to Andrea Charles from Pharma IQ, about h ow can we improve pharmaceuticals through co-crystals and overcoming the var | 9/8/10 | Free | View In iTunes |
|
177 |
Was sind die Herausforderungen auf der letzten Meile zum Patienten? | In diesem Interview spricht Walter Heider, Director Commercial Department und Business Development bei der Sanofi-Aventis GmbH, über qualifizierte und zukunftsfähige Transportmöglichkeiten, und Herausforderungen in der Pharma Distribution. | 9/7/10 | Free | View In iTunes |
|
178 |
Integration and Interoperability in the Laboratory: Will You Find Your Match? | You may have some or all of your informatics systems in place, and they may work well, but chances are good they do not work well together. Perhaps nowhere is this more noticeable than after mergers, when two or more firms need to be able to access and jo | 9/1/10 | Free | View In iTunes |
|
179 |
Conducting Effective Clinical Evaluations for Medical Devices | In this podcast Sven Knoke, Quality and Regulatory Affairs Manager at Siemens, speaks to Andrea Charles from Pharma IQ, about conducting effective clinical evaluations for medical devices and achieving market access by executing thorough clinical lit | 8/25/10 | Free | View In iTunes |
|
180 |
3rd Party Integration: Mitigating Risks | In this interview Béatrice Serckx, Associate Director, Drug Production Industrial Strategy and CMO Management, UCB Pharma, speaks to Andrea Charles from Pharma IQ, about the hurdles to successful supplier integration and how to measure the success | 8/25/10 | Free | View In iTunes |
|
181 |
Corporate Whistleblowing in Pharma | Shaul Brazil, a lawyer at BCL Burton Copeland, represented Robert John Dougall, the first executive to be prosecuted by the Serious Fraud Office (SFO) for overseas corruption. The case arose out of corrupt practices in the supply of orthopaedic prod | 8/23/10 | Free | View In iTunes |
|
182 |
Logistics for Clinical Trials in Emerging Markets | Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for logistics in emerging countries. He also talks about the n | 8/19/10 | Free | View In iTunes |
|
183 |
Essential Tips for Successful Outsourcing of Your Compound Management Activity | In this exclusive interview, Dr. Sylviane Boucharens, Section Head of Molecular Pharmacology Department at MSD, speaks to Andrea Charles from Pharma IQ, about the current hurdles to accurate compound management and integrity, and the benef | 8/16/10 | Free | View In iTunes |
|
184 |
High Risk: How Corrupt is Life Sciences? | According to Transparency International's Bribe Payers Index, among 19 industry sectors globally, life sciences is perceived to be the 6th most corrupt sector, in terms of the propensity of companies to pay bribes. In this exclusive interview Cha | 8/11/10 | Free | View In iTunes |
|
185 |
Keeping the Pharma Sales Door Open | Daniel Schick, Executive Director, Commercial Affairs & Key Account Management for Janssen-Cilag, spoke to Andrea Charles from Pharma IQ, about the current challenges facing pharmaceutical sales force effectiveness. In this podcast,&nbs | 8/3/10 | Free | View In iTunes |
|
186 |
How to Analyse Bioactivity in Large Compound Libraries? | Dr. Steffen Renner, Investigator II, Molecular and Library Informatics at Novartis Pharma AG, speaks to Andrea Charles from Pharma IQ, about the current challenges relating to compound storage and retrieval and how are these issues affecting the succ | 8/2/10 | Free | View In iTunes |
|
187 |
Das Arzneimittelsparpaket: Wie kann sich die Pharmaindustrie auf die neuen Rahmbedingungen einstellen? | In this Pharma IQ podcast, Isabel Henkel, Director, Access & Reimbursement at Johnson & Johnson Medical, talks about how the pharma industry needs to adjust to the new requirements of the German government’s pharmaceutical savings progr | 7/28/10 | Free | View In iTunes |
|
188 |
Best Practice Tips for Overcoming Obstacles in Biomarker Development | How can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses with Helen Winsor from Pharma IQ, the key challenges in | 7/28/10 | Free | View In iTunes |
|
189 |
Exklusives Interview mit Dr. Elizabeth Storz | Hören Sie hier ein exklusives Interview mit Dr. Elizabeth Storz, Referentin Arzneimittelsicherheit beim vfa - Verband der forschenden Pharma-Unternehmen, zum Thema 'Auswirkungen des EU-Pharma Pakets auf die Pharmakovigilanz'. | 7/25/10 | Free | View In iTunes |
|
190 |
The Economics of Fighting Infectious Disease | How do you deliver a vaccine that can only cost a dollar, to the whole population of a country, and still make a profit for the pharmaceutical company that is developing it? Dr. Donald Francis vaccine pioneer and Executive Director of Global Solutions for | 7/25/10 | Free | View In iTunes |
|
191 |
Pharmacy: The Front Line in Detecting Counterfeit Drugs | Pharmacists are the last player in the distribution chain, and the ones who have the most interaction with the patient. John Chave, Secretary General of the Pharmaceutical Group of the European Union, speaks to Andrea Charles from Pharma IQ, about the cur | 7/22/10 | Free | View In iTunes |
|
192 |
Top Tips for Preparing Health Technology Submissions | Dr. Franz Hessel, Director of International Health Economics Outcomes Research at Abbott, talks to Andrea Charles from Pharma IQ, about the approaches authorities in leading pharmaceutical markets have taken to the use of Health Techn | 7/22/10 | Free | View In iTunes |
|
193 |
Converting Problems into Opportunities When Building Up a Biobank | Pharma IQ is joined by Mark Divers, Executive Director, KI Biobank at Karolinska Institute, to discuss some of the prevalent aspects in the growing field of biobanking, from international partnerships to standardising protocol. | 7/15/10 | Free | View In iTunes |
|
194 |
Re-sculpting the Pfizer Screening File | Dr. Andy Bell, Research Fellow at Sandwich Laboratories Worldwide R&D, Pfizer, shares his insights on Pfizer's review of their screening file, prior to the merger with Wyeth in 2009. He also discusses with Pharma IQ, | 7/14/10 | Free | View In iTunes |
|
195 |
Top Tips for Ensuring Seamless Integration between Processes and IT Systems | Pharma IQ caught up with Dr. Wolfgang Schmitt, Business Development Manager Pharma at IDS Scheer, to discuss the challenges which arise when optimising supply chains and how we should seek to improve S&OP. | 7/13/10 | Free | View In iTunes |
|
196 |
Working Towards Achieving True Co-Crystal Solubility | Prof. Nair Rodriguez-Hornedo of the University of Michigan, discusses the latest successful strategies in making co-crystals, providing firsthand examples from the University's Department of Pharmaceutical Sciences. She offers her perspective on the m | 7/11/10 | Free | View In iTunes |
|
197 |
How to Build a Robust Patent Strategy | Dr. Morten Rosted, Head of Department, DK Patents, Corporate Patents & Trademarks at H. Lundbeck A/S, speaks to Pharma IQ about the spectrum of capabilities needed in biopatent design and how to build a robust patent strategy. | 7/11/10 | Free | View In iTunes |
|
198 |
How to Unify the Requirements of Chemistry and Biology with a Single ELN | Pharma IQ are joined today by Dr. Ian Berry, Principal Scientist, Applications Developer and eScience Manager for Evotec UK, to discuss Evotec's experiences of piloting and integrating an ELN. What Does The Future Hold For Electroni | 7/1/10 | Free | View In iTunes |
|
199 |
How ELNs Can Help Maximise Biopharmaceutical Lab Efficiency | Discover first hand how Roche deployed an ELN within the biopharmaceutical area. This interview with Ralph Haffner, Head of Biologic Research Informatics at Roche, documents the drivers, the planning and selection phase, through to the deployment and inte | 6/30/10 | Free | View In iTunes |
|
200 |
The Genentech ELN story | Spending less time on paperwork is a goal for all companies and the pharmaceutical industry is no different. In this Pharma IQ recording, John Trigg, Director, phaseFour Informatics caught up with Martin Vanderlaan, Director of Analytical Operat | 6/30/10 | Free | View In iTunes |
|
201 |
Testing for Genotoxic Impurities: How Low Should We Go? | Patient safety is a paramount concern for the pharmaceutical industry. Overlooked toxicity liability could not only put patient safety at risk, but also have huge financial implications for a pharmaceutical company. Dr. Fenghe Qiu, Princip | 6/24/10 | Free | View In iTunes |
|
202 |
Managing Tender Risks | Supply chain plays a pivotal role, in balancing flexibility against a desired need for stability and standardisation. Madlene Dole, Head of NPhS Supply Chain, Novartis Pharma AG, joins us to discuss the challenges of tender business and global demand plan | 6/17/10 | Free | View In iTunes |
|
203 |
Public Private Partnerships: A Working Model for Open Innovation | How can we widen the real of pre-competitive science? Dr. Johan Weigelt, Chief Scientist of the Structural Genomics Consortium at the Karolinska Institute, joined Pharma IQ to discuss the benefits for R&D restructuring, and how Public Privat | 6/14/10 | Free | View In iTunes |
|
204 |
Choosing the Best Techniques for Developing Amorphous Materials | The amorphous state is inherently instable. How do we keep amorphous forms from crystallising for as long as possible? Dr. Joseph Lubach from Genentech, joined Pharma IQ to discuss the challenges of physical and chemical stability, as well as techniques b | 6/13/10 | Free | View In iTunes |
|
205 |
Successful Strategies for eCTD Submission | Ensuring eCTD readiness is now critical for gaining first time market approval. Dr. Klaus Menges from the Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, Bfarm joins Pharma IQ to discuss strategies for successful | 6/13/10 | Free | View In iTunes |
|
206 |
Minimising the Risk of Regulatory Censure | Dr. Philippe Auby Senior Medical Director, Corporate ICR France & Paediatrics, Lundbeck joins Pharma IQ to share his insights on minimising the risk of regulatory censure in paediatric clinical development. | 5/31/10 | Free | View In iTunes |
|
207 |
Strategies for Selecting CROs and Keeping Partnerships on Track | Antonio Llamas, Regional Head of Operations in Spain & Portugal for Wyeth Research, joins us to discuss recent changes in the market, the process of selecting a CRO to partner with and subsequently maintaining a smooth relationship. | 5/20/10 | Free | View In iTunes |
|
208 |
Pharmaceutical and Biotech Patent Litigation - Vineet Kohli | Vineet Kohli, Assistant Patent Counsel at Merck & Co., Inc., talks to Pharma IQ about the topics interesting him in the industry at present, the recent impacts in the law regarding patenting antibodies , and developments for the strategies of internal | 5/12/10 | Free | View In iTunes |
|
209 |
Clinical Data Standardisation and Management: Where Do We Stand? | In this podcast Andrew Miller, Director of Clinical Information Standards at Astrazeneca, discusses data management and the efforts to standardise. | 5/11/10 | Free | View In iTunes |
|
210 |
Changes in Rabies Inoculations | In this podcast, Charles Rupprecht, Chief of the Rabies Program at the CDC, describes the advancements in rabies inoculations. Previously, when a person was treated for rabies he received five shots of the vaccination. However, now the CDC is recommending | 5/6/10 | Free | View In iTunes |
|
211 |
Successfully Acquiring a Biosimiliar in Drug Delivery for Partnering | Pharma IQ interviews Christopher Slavinsky, Assistant General Council, Established Products Brand, Pfizer, Inc., who discusses how to successfully acquire a biosimiliar in drug delivery for partnering. | 4/26/10 | Free | View In iTunes |
|
212 |
Avoiding Common Mistakes and Pitfalls for Clinical Trials in Emerging Countries | Pharma IQ hosts Sarah and Simon speak to Steve Jacobs, President of Global BioPharm Solutions and former President of Bilcare Global Clinical Supplies, about avoiding common mistakes and pitfalls for clinical trials in emerging countries. | 3/17/10 | Free | View In iTunes |
|
213 |
The Changing Fortunes of Antibacterial Drug Development and Commercialisation | The global market for anti-infective drugs is steadily growing and projected to increase by over 50% by the year 2015, to total US $100 billion. In this Pharma IQ interview Dr. Chris Thomson, Director of Licensing & Business Development at Astell | 3/17/10 | Free | View In iTunes |
|
214 |
A Novel Therapeutic Strategy to Cutaneous Infection | Join Pharma IQ as we speak with Dr. Adam Friedman, Chief Resident in the Dept of Dermatology at Albert Einstein College of Medicine and speaker at the IQPC Anti-Infectives Summit Jan 25-27 in Philadelphia, PA. His topic covers Sustained Release of Nitric | 3/17/10 | Free | View In iTunes |
|
215 |
Efficient and On-Time Shipment of Global Clinical Supplies | Join Pharma IQ as we speak with Jeff Sitzlar, who does business development for FedEx Custom Critical and is a participant at the Clinical Trials Logistics Conference where he will speak in a panel discussion on efficient and on-time shipment of global cl | 3/17/10 | Free | View In iTunes |
|
216 |
An Architecture-based Framework for Biomarker Discovery and Management in the Early Detection and Research | Pharma IQ speaks with Chris Mattmann, Ph.D., Senior Computer Scientist, NASA Jet Propulsion Laboratory, about an architecture-based framework for biomarker discovery and management in the early detection research network. | 3/16/10 | Free | View In iTunes |
|
217 |
Making Development of an Insoluble Drug Candidate Possible by Using Solid Dispersions: A Case Study | Pharma IQ interviews Satej Bhandarkar, PhD, Senior Manager, Analytical Sciences Department at Sanofi-Aventis U.S. and speaker at IQPC's 4th Improving Solubility summit, March 29-31 in Philadelphia. For more info, please visit improvingsolubility.com . | 3/16/10 | Free | View In iTunes |
|
218 |
Developing and Optimising Data Management Processes to Assist Business Decision-Making | Michael Elliott, CEO, Atrium Research & Consulting LLC, speaks to Pharma IQ, about developing and optimising data management processes to assist business decision-making. | 3/16/10 | Free | View In iTunes |
|
219 |
Optimising Your Clinical Supply Chain | Listen to Vladimir Shnaydman, PhD, and President of ORBee Consulting address capacity planning, resource allocation and scheduling for clinical trials. He will be a speaker at the IQPC's 2nd Clinical Trials Logistics Conference on 15th-17th Novem | 3/16/10 | Free | View In iTunes |
|
220 |
Applying 21 CFR Part 11 to the Laboratory Environment to Ensure Quality and Compliance | Pharma IQ speaks with Sandy Weinberg, Ph.D., Associate Professor of Health Care Management, Clayton State University, about applying 21 CFR Part 11 to the laboratory environment to ensure quality and compliance. | 3/15/10 | Free | View In iTunes |
|
221 |
Prioritising and Executing Lean Transformation Projects to Align with Business | Paul Nelson, Supply Chain Senior Director and Lean Transformation Leader at Shire Pharmaceuticals, speaks to Pharma IQ, about what it takes to successfully prioritise and execute Lean transformation projects to align with business and organisational | 3/15/10 | Free | View In iTunes |
|
222 |
Implementing and Managing a Lean Six Sigma Culture in Biopharmaceuticals | Lyndi Gillespie and Deepa Kumar, Operational Excellence experts within Global Manufacturing and Supply Biopharmaceuticals for GlaxoSmithKline, speak to Pharma IQ about the Lean Six Sigma culture in biopharmaceuticals . Gillespie and Kumar share how | 3/15/10 | Free | View In iTunes |
|
223 |
Business Process Kaizen Implementation and Performance Improvement | Pharma IQ interviews Charles Aubrey, Vice President Performance Excellence, Anderson Pharmaceutical Packaging. | 3/15/10 | Free | View In iTunes |
| Total: 223 Episodes |
Listeners also subscribed to
- BIOtechNow
- Biotechnology Industry Organization
- View In iTunes
- Pharm Exec Podcast Interviews
- Advanstar Communications
- View In iTunes
- PharmaMedDevice Official Podcast
- Reed Life Sciences
- View In iTunes
- Food and Drug Administration Drug Safety Podcast
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research
- View In iTunes
- PharmaVOICE Podcasts
- Daniel Limbach
- View In iTunes
